Skip to main content

Trinity College Dublin, The University of Dublin

Trinity Menu Trinity Search



You are here Research > News > 2020

2020 News

TRINITY RESEARCHERS DRIVE LUNG CANCER RESEARCH TOWARDS NON-ANIMAL MODELS
School of Medicine PIs to Star at START European Researcher’s Night
Meet our PhD researcher - Dale Whelehan
Scientists pinpoint two new potential therapeutic targets for rheumatoid arthritis
Welcome to our IRC Scholars as they embark on their PhD research
Meet our PhD researcher and IRC 2020 Scholar - Isabella Batten
Meet our researcher – Oisín C. Joyce - PhD Student Physiology
Meet our researcher – Serena Foo - PhD Student Clinical Medicine
Meet our researcher - Jason McGrath – PhD Student Surgery
Meet our school Researchers – Aisling Heeran - PhD Student Surgery
Opportunity to work in Ireland as post doc in a Globally recognised University and one of Ireland’s leading innovation companies
Meet our school researchers – Laura Kane, PhD Student Surgery
Q&A with emerging academic research leader, Dr Laura Gleeson
New study demonstrates a lack of high quality studies investigating physical activity and brain health in children with potential bias towards promoting benefits of physical activity.
High levels of frailty among homeless people
Open 6-month Postdoc Opportunity
How blocking iron drives the lung immune system to control infection
Inspiring précis of research-led response to COVID
Potential new therapeutic target for eye disease
PhD Position in Respiratory Biochemistry and Immunology
1st person with haemophilia in Ireland to be treated with ground-breaking gene therapy
Sláintecare TCD Researcher nominated as HRB Research Leader
Adults over 70 are the fabric of their community and deserve acknowledgement of this during the COVID-19 crisis
Research into early detection of frailty in older adults awarded €1.5m
HRB Award is huge boost for paediatric psychiatry research in TCD
School of Medicine Researcher is honoured for Cancer Research
Palliative care patient needs to increase in next 25 years
How bacterial evolution of antibiotic arsenals is providing new blueprints for drug designers